Skip to main content

Table 4 Estimated means (SE) on EQ-5D-5L index and VAS from mixed regressions at pre-treatment and 3-month follow-up

From: First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study

 

Baseline

Follow-up

Z

p

ES

EQ-5D index

 All patients

0.715 (0.01)

0.779 (0.01)

6.23

< .001

0.38

 Type 2 diabetes

0.842 (0.02)

0.859 (0.02)

0.95

.342

0.15

 Chronic low back pain

0.621 (0.01)

0.725 (0.02)

6.93

< .001

0.54

 Long COVID

0.748 (0.02)

0.796 (0.02)

2.45

.014

0.33

 Norwegian population norm23

0.805

   

EQ VAS

 All patients

54.1 (1.03)

62.8 (1.15)

6.45

< .001

0.53

 Type 2 diabetes

65.8 (2.08)

69.1 (2.14)

1.32

.185

0.23

 Chronic low back pain

47.4 (1.51)

56.7 (1.73)

4.70

< .001

0.58

 Long COVID

54.2 (1.86)

67.1 (2.19)

5.14

< .001

0.78

 Norwegian population norm23

77.9

   
  1. ES Effect size computed as \(\mathrm G\mathrm l\mathrm a\mathrm s\mathrm s'\mathrm s\;\mathrm\Delta=\frac{M_{pre}-M_{post}}{{SD}_{pre}}\)